Investor Class Action Filed Against Taro Pharmaceutical Industries Ltd. for Securities Fraud Violations
Company Name: Taro Pharmaceutical Industries Ltd
Court: United States District Court for the Southern District of New York
Case Number: 16-cv-8318
Judge: The Hon. Andrew L. Carter, Jr.
Class period: Between July 2, 2014 and November 3, 2016
Security Type:

Case Background:

On October 25, 2016, the initial complaint in this securities class action was filed against Taro Pharmaceutical Industries Ltd. (“Taro”), and certain of Taro’s directors and officers, asserting violations of sections 10(b) and 20(a) of the Securities Exchange Act.  Lead Plaintiff alleges that defendants made false and misleading statements, causing investors to reasonably assume that Taro’s sales figures relating to its generic drugs were an accurate representation of the success of Taro’s products in a competitive market. Lead Plaintiff further alleges that those sales figures were inflated as a result of Taro’s anti-competitive conduct and did not reflect the sales Taro would have been able to achieve absent its price-fixing activity.

Current Status of Case:

Pursuant to a stipulation ordered by the Court on April 17, 2019, fact discovery in this action is presently coordinated with discovery in the multidistrict litigation, captioned In re Generic Pharmaceuticals Pricing Antitrust Litigation, No. 2:16-md-2724 however, this action is otherwise stayed. Fact discovery remains ongoing in the multidistrict litigation.

If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.

Kessler Topaz Meltzer & Check, LLP
James Maro, Esq. or Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087 1-844-887-9500 (toll free) or 1-610-667-7706
Or by e-mail at

Please complete this form and list your purchase and sale transaction(s) for Taro Pharmaceutical Industries Ltd. (NYSE: TARO) securities between July 2, 2014 and November 3, 2016, both dates inclusive (the “Class Period”):

You may also contact James Maro, Jr., Esq. or Adrienne Bell, Esq. at 610.667.7706 or toll free at 844.887.9500, or you may submit your information via email at, or you may click here to print a PDF of this form.

* Denotes required field
# of Shares
Price per Share
Principal Amount
Amount Paid
Series or CUSIP
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of Taro Pharmaceutical Industries Ltd. (2016) prior to the Class Period?
Are you a current or former employee of Taro Pharmaceutical Industries Ltd. (2016)?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC
I would like to receive
new case alerts by email